Apr 20, 2023
This week we interview Dave Kuraguntla, the co-founder and CEO of Alio, a medical technology company reinventing chronic disease management. After serving in the Air Force, Dave was selected for a fellowship that allowed him to attend medical school. He received his medical degree in osteopathic medicine (D.O.). He was preparing for a surgical residency when he experienced firsthand the need for better technological solutions for those with chronic conditions.
Drawing on his experience as a former NIH researcher, Dave began to explore the potential of noninvasive wearables for conditions like End Stage Kidney Disease (ESKD). Since then, Alio has secured $53 million in funding to date and formed key strategic partnerships with organizations like the NHS in the UK and US Renal Care. For more information, visit www.alio.ai.